Ayurveda management in cancer side effects

Evaluation of Jeevanthyadi Ghrita matra basti on Chemo-radiation induced adverse events in cancer patients - JGMB in CCRT

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032043

Enrollment

140

Registered

2021-03-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 3: C159- Malignant neoplasm of esophagus, unspecified Health Condition 4: C109- Malignant neoplasm of oropharynx,unspecified Health Condition 5: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Jeevanthyadi Ghrita Matra Basti: 50 ml of Jeevanthyadi Ghrita will be given through rectal route in between radaition schedules. Control Intervention1: Concurrent Chemotherpay and Radia

Eligibility

Inclusion criteria

Inclusion criteria: ECOG Eligible for Matra Basti Acceptable Base line Hametological and Biochemical values

Exclusion criteria

Exclusion criteria: K/C/O IHD, Thyroid Haemorrhoids Acute Diarrhoea Second Cancers Concomitant Major Illness requiring long term medications

Design outcomes

Primary

Measure	Time frame
Quality of Life with EORTC-QLQ 30 questionarre Amelioration of Adverse events ECOGTimepoint: Day 0 Day 19 Day 49	—

Secondary

Measure	Time frame
Safety profile done as per KCTRI Complete blood count Liver function test and Renal function testTimepoint: Day 0 DAy 19 Day 49	—

Countries

India

Contacts

Public ContactDr Santosh F Patil

KLE University

dr.santosh19@gmail.com09886633099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026